Background: Pigmented lesions from chronic UV photoaging are extremely common on the face and hands.
Objective: To evaluate the safety and efficacy of a 532-nm picosecond laser for these types of pigmented lesions.
Methods: This was a single-center, prospective, open-label clinical trial.